The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm

Medicine (Baltimore). 2017 Jan;96(2):e5809. doi: 10.1097/MD.0000000000005809.

Abstract

Colorectal neoplasm is considered to have a strong association with nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS), respectively. The relationship among NAFLD, MetS, and colorectal neoplasm was assessed in 1793 participants. Participants were divided into 4 groups based on the status of NAFLD and MetS. Relative excess risks of interaction (RERI), attributable proportion (AP), and synergy index (SI) were applied to evaluate the additive interaction. NAFLD and MetS were significantly correlated with colorectal neoplasm and colorectal cancer (CRC), respectively. The incidence of CRC in NAFLD (+) MetS (+) group was significantly higher than other 3 groups. The result of RERI, AP, and SI indicated the significant additive interaction of NAFLD and MetS on the development of CRC. NAFLD and MetS are risk factors for colorectal neoplasm and CRC, respectively. And NAFLD and MetS have an additive effect on the development of CRC.

Publication types

  • Observational Study

MeSH terms

  • Colonoscopy
  • Colorectal Neoplasms / complications
  • Colorectal Neoplasms / epidemiology*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Incidence
  • Male
  • Metabolic Syndrome / complications
  • Metabolic Syndrome / epidemiology*
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / complications
  • Non-alcoholic Fatty Liver Disease / epidemiology*
  • Retrospective Studies
  • Risk Factors